2BB score and signals
RenovoRx, Inc.’s current 2BB score is 15 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 6 | Very Low |
| Momentum | 20 | Strongly Weakening |
| Financial strength | 41 | Normal |
| Quality | 40 | Normal |
| Risk | 47 | Moderate |
Company facts
| Founded | 2009 |
| Employees | 17 |
| 52-week range | $0.70 – $1.45 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.0578 | — | $1.11M |
| 2026-08-12 | — | -0.074 | — | $730,830.00 |
| 2026-05-14 | -0.09 | -0.0816 | $563,000.00 | $472,515.00 |
| 2026-03-30 | -0.08 | -0.0816 | $238,000.00 | $428,145.00 |
Related companies